![]() |
市場調查報告書
商品編碼
2046568
醫療和外科引流系統市場-全球產業規模、佔有率、趨勢、機會和預測:按產品類型、應用、流速類型、材料類型、地區和競爭格局分類,2021-2031年Medical and Surgical Drainage System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By Flow Type, By Material Type By Region & Competition, 2021-2031F |
||||||
全球醫療和外科引流系統市場預計將從 2025 年的 29.8 億美元成長到 2031 年的 39.6 億美元,複合年成長率為 4.85%。
這些專用治療設備對於引流傷口和體腔內多餘的液體、氣體和血液至關重要,能夠防止體液積聚,促進患者康復。市場排放的主要驅動力是全球外科手術頻率的增加(尤其是在整形外科、腫瘤科和整形外科領域),而這又歸因於人口老化和慢性病的普遍存在。例如,國際美容整形外科學會(ISAPS)報告稱,2024年全球將進行超過1740萬例手術,凸顯了術後液體管理解決方案對於預防血清腫和血腫形成的重要性。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 29.8億美元 |
| 市場規模:2031年 | 39.6億美元 |
| 複合年成長率:2026-2031年 | 4.85% |
| 成長最快的細分市場 | 被動的 |
| 最大的市場 | 北美洲 |
然而,該市場面臨醫療相關感染風險的重大挑戰,尤其是手術部位感染以及與長期使用醫療設備相關的導管併發症。鑑於這些不利事件的潛在風險,必須嚴格遵守感染控制規程和法規,這導致營運成本增加。因此,這些經濟和安全負擔可能會阻礙資源匱乏的醫療機構採用侵入性引流系統,並最終阻礙市場的進一步擴張。
全球外科手術量的激增是醫療和外科引流系統市場的主要成長要素。隨著醫療系統積極應對候診名單過長和人口老化問題,整形外科、循環系統和普通外科手術的數量顯著增加,凸顯了有效液體管理以避免術後併發症的日益成長的需求。手術量的增加推動了主動和被動引流裝置的使用,這些裝置用於減少血腫和漿液腫,最終使患者能夠更早出院。英國國家醫療服務體系(NHS)英格蘭分部發布的2025年7月「月度手術統計數據」凸顯了這一成長趨勢,數據顯示,2025年5月,醫務人員完成了創紀錄的150萬例擇期手術,這凸顯了在高手術量環境下對引流解決方案的持續依賴。
同時,癌症和心血管疾病等慢性疾病在全球發病率的上升是市場擴張的重要支柱。這些複雜的疾病通常需要進行切除術和開胸手術等侵入性手術,並且不可避免地需要依靠引流系統來控制體液並防止積液。根據美國癌症協會於2025年1月發布的《2025年癌症事實與數據》報告,預計2025年美國將新增2,041,910例癌症病例,這凸顯了需要手術治療和引流療法的患者群體不斷擴大。這種需求是製造商的主要收入來源,而康維特集團於2025年2月發布的《年度財務表現》也反映了手術引流相關治療方法的經濟規模,其高級傷口護理業務的銷售額達到7.43億美元。
醫療相關感染的持續威脅對醫用和外科引流系統市場的成長構成重大障礙。由於侵入性引流裝置可能成為病原體的入侵途徑,並可能導致手術部位感染和導管相關併發症,醫療機構必須執行嚴格且成本高昂的感染控制方案。這些必要的安全措施,包括專門的消毒流程、持續的病患監測以及嚴格遵守複雜的法規,都會顯著增加營運成本。因此,高成本限制了先進引流系統的經濟可行性,尤其是在預算緊張的小規模醫療機構和醫療機構。
在發展中地區,由於無法有效控制感染風險,市場滲透受到阻礙,這項挑戰尤其嚴峻。世界衛生組織(世衛組織)2024年的報告顯示,中低收入國家的病患感染醫療相關感染疾病的可能性是高所得國家病患的20倍之多。這種顯著差異表明,在資源匱乏的環境中,由於可能出現代價高昂的不利事件,侵入性引流技術的使用受到限制。因此,全球相當一部分人口被排除在目標市場之外,直接阻礙了整個產業的成長。
數位式和自動化胸管引流系統的快速普及,正從根本上改變術後護理,以精準的即時數據量化取代主觀的模擬評估。這些先進設備採用智慧軟體和感測器技術,持續監測漏氣和引流量,顯著降低觀察者差異,並有助於更早做出臨床決策。透過自動化負壓控制,這些系統可減少殘餘血症候群等併發症,並加速複雜心臟和胸腔外科手術患者的復原。這項變革的臨床價值顯而易見。例如,Centese公司於2025年4月發布的新聞稿題為“新研究表明Thoraguard自動化胸管引流系統顯著改善患者康復”,指出與傳統胸管相比,使用其自動化系統可使術後房顫發生率降低41%,這正推動著主動式數位引流技術的普及。
同時,隨著攜帶式門診和居家照護可攜式系統的出現,醫療服務提供者正逐步分散復健方案以緩解醫院容量限制,市場格局也隨之改變。這一趨勢包括開發輕鬆易用的引流裝置,專門用於在傳統病房外安全管理慢性胸膜炎和腹水。急性居家照護報銷模式的擴展正在加速對這些行動解決方案的需求,使患者能夠在接受治療的同時保持行動能力和生活品質。 Inbound Health 在 2025 年 3 月發表的報導《居家醫院服務再持續六個月》反映了這一結構性轉變,該文章指出,美國醫療保險和醫療補助服務中心 (CMS) 的「居家急性醫院護理」計劃已擴展至 350 多家核准醫院,為攜帶式引流系統的推廣應用奠定了關鍵基礎。
The Global Medical and Surgical Drainage System Market is projected to expand from USD 2.98 Billion in 2025 to USD 3.96 Billion by 2031, registering a CAGR of 4.85%. These specialized therapeutic devices are essential for evacuating excess fluids, air, or blood from wounds and body cavities to prevent accumulation and accelerate patient recovery. The market's upward trajectory is primarily underpinned by the increasing global frequency of surgical interventions-especially within orthopedics, oncology, and aesthetics-stemming from an aging population and the prevalence of chronic diseases. For example, the International Society of Aesthetic Plastic Surgery reported over 17.4 million surgical procedures globally in 2024, emphasizing the critical need for postoperative fluid management solutions to prevent seroma and hematoma formation.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.98 Billion |
| Market Size 2031 | USD 3.96 Billion |
| CAGR 2026-2031 | 4.85% |
| Fastest Growing Segment | Passive |
| Largest Market | North America |
However, the market faces a significant obstacle regarding the risk of healthcare-associated infections, particularly surgical site infections and complications related to catheters due to prolonged device use. The possibility of these adverse outcomes mandates strict adherence to infection control protocols and regulatory compliance, which drives up operational costs. Consequently, these financial and safety burdens can discourage the adoption of invasive drainage systems in healthcare settings with limited resources, thereby impeding broader market expansion.
Market Driver
The surging volume of surgical procedures worldwide serves as a major growth driver for the Medical and Surgical Drainage System Market. As healthcare systems actively work to clear waitlist backlogs and accommodate an aging demographic, the number of orthopedic, cardiovascular, and general surgeries has risen significantly, creating a need for effective fluid management to avoid postoperative complications. This increased operative throughput fuels the consumption of active and passive drainage devices required to mitigate hematomas and seromas, ultimately facilitating quicker patient discharge. Data from NHS England's 'Monthly operational statistics' in July 2025 highlighted this operational intensity, revealing that healthcare staff delivered a record 1.5 million elective treatments in May 2025, confirming the sustained reliance on drainage solutions in high-volume environments.
Concurrently, the growing global incidence of chronic conditions, such as cancer and cardiovascular diseases, serves as a fundamental pillar of market expansion. These complex pathologies frequently necessitate invasive interventions like mastectomies or thoracostomies, which invariably rely on drainage systems to manage bodily fluids and prevent accumulation. According to the 'Cancer Facts & Figures 2025' report by the American Cancer Society in January 2025, an estimated 2,041,910 new cancer cases will be diagnosed in the US in 2025, underscoring the expanding patient pool requiring surgical care and drainage therapy. This demand drives significant revenue for manufacturers, as evidenced by Convatec Group's 'Annual Results' in February 2025, where their Advanced Wound Care business reported revenues of $743 million, demonstrating the financial scale of therapies linked to surgical drainage.
Market Challenge
The persistent threat of healthcare-associated infections stands as a formidable barrier to the growth of the medical and surgical drainage system market. Since invasive drainage devices can act as pathways for pathogens, potentially causing surgical site infections and catheter-related complications, healthcare facilities must enforce rigorous and costly infection control protocols. These essential safety measures, which include specialized sterilization processes, continuous patient monitoring, and strict compliance with complex regulations, significantly elevate operational expenditures. Consequently, the high costs associated with compliance limit the financial feasibility of adopting advanced drainage systems, particularly for smaller facilities or institutions operating under tight budgetary constraints.
This challenge is particularly acute in developing regions, where the inability to effectively manage infection risks hampers market penetration. According to the World Health Organization in 2024, patients in low- and middle-income countries faced a risk of acquiring healthcare-associated infections that was up to 20 times higher than that of patients in high-income nations. This significant disparity suggests that in resource-constrained environments, the potential for costly adverse events discourages the utilization of invasive drainage mechanisms. As a result, a substantial segment of the global population is excluded from the addressable market, directly stifling overall industry growth.
Market Trends
The rapid adoption of digital and automated thoracic drainage systems is fundamentally revolutionizing postoperative care by replacing subjective analog assessments with precise, real-time data quantification. These advanced devices employ intelligent software and sensor technology to continuously monitor air leaks and fluid output, thereby significantly reducing inter-observer variability and facilitating earlier clinical decision-making. By automating negative pressure regulation, these systems mitigate complications such as retained blood syndrome and enhance patient recovery in complex cardiothoracic procedures. The clinical value of this shift is evident; for instance, a 'New Study Demonstrates Thoraguard Automated Chest Tube System Significantly Improves Recovery' press release by Centese in April 2025 noted a 41% reduction in postoperative atrial fibrillation with their automated system compared to conventional chest tubes, driving the transition toward active digital drainage technologies.
Simultaneously, the emergence of portable systems for ambulatory and home care settings is reshaping the market landscape as providers increasingly decentralize recovery protocols to relieve hospital capacity constraints. This trend involves the development of lightweight, user-friendly drainage devices tailored for the safe management of chronic pleural effusions and ascites outside traditional inpatient wards. The expansion of reimbursement models for home-based acute care is accelerating demand for these mobile solutions, allowing patients to maintain mobility and quality of life during therapy. Reflecting this structural shift, Inbound Health's March 2025 article, 'Six More Months of Hospital-at-Home', reported that the Centers for Medicare & Medicaid Services Acute Hospital Care at Home program has grown to include over 350 approved hospitals, establishing a substantial channel for deploying portable drainage systems.
Report Scope
In this report, the Global Medical and Surgical Drainage System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Medical and Surgical Drainage System Market.
Global Medical and Surgical Drainage System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: